IP Library Granted Patent US 8,617,621
Granted Patent B2
US 8,617,621 · App. 13/202,868 · Granted Dec 31, 2013

Composition for enhancing immunity containing plant stem cell line derived from cambium of

Inventors: Min Jung Lim (Jeonbuk, KR); Young Woo Jin (Jeonbuk, KR); Eun Kyong Lee (Jeonbuk, KR)
Assignees: Unhwa Corporation; Young Woo Jin; Eun Kyoung Lee
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,617,621
App. No.
13/202,868
Granted
Dec 31, 2013
Kind
B2
Abstract

The present invention relates to a composition for enhancing immunity, comprising one or more of the following: a homogenous cell line, and a lysate, an extract and a culture medium thereof as an active ingredient. The homogenous cell line, the lysate, the extract and the culture thereof according to the present invention, which are derived from a natural product, minimize adverse side effects of prior immune enhancing agents and safe for the human body. Further, they effectively increase the activity of NK cells responsible for innate immunity, as well as increase the proliferation rate of lymph node cells when the cells were re-exposed to an antigen in a specific immune reaction to enhance acquired immunity, and thus are useful as an immune enhancing agent. In particular, the homogenous cell line, the lysate, the extract, and the culture thereof according to the present invention also effectively increase the number of hone marrow cells, thus are not only used as an adjuvant in an immune reaction, but also used in the prevention and treatment of anemia through hematopoiesis.

Claims (9)

1. A method for enhancing immunity in a mammal, comprising administering to the mammal one or more of the following: a cell line, a lysate of the cell line, an extract of the cell line, and a culture of the cell line, wherein the cell line is: derived from the cambium of Panax ginseng, is in an innately undifferentiated state, and is not callus.

2. The method of claim 1 , wherein the cell line is present as single cell level during a suspension culture.

3. The method of claim 1 , wherein the cell line is obtained by using an isolation method comprising the steps of: (a) obtaining a Panax ginseng cambium-containing storage root tissue; (b) culturing the cambium-containing storage root tissue in a medium supplemented with indole-3-acetic acid or indole-3-butyric acid to induce a cell line derived from the cambium, wherein an osmotic stress is applied to the cambium-containing storage root tissue before, during, or after the culture; and (c) collecting the induced, cambium-derived cell line.

4. The method of claim 3 , which further comprises culturing the cell line collected in step (c) in a medium supplemented with an elicitor and collecting the cell line.

5. The method of claim 3 , wherein step (c) is performed by proliferating the induced cambium-derived cell line in a medium which contains one or more of 2,4-dichlorophenoxyacetic acid, picloram and IBA, and then collecting the cambium-derived cell line.

6. The method of claim 4 , wherein the elicitor is raw sugar or methyl jasmonate.

7. The method of claim 1 , wherein the extract is obtained by extracting the cell line with a solvent selected from the group consisting of distilled water, alcohol, acetone, dimethyl sulfoxide and a mixture thereof.

8. The method of claim 1 , wherein any one among the cell line and the lysate, the extract and the culture thereof has an immune enhancing effect by increasing the activity of NK cells.

9. The method of claim 1 , wherein any one among the cell line and the lysate, the extract and the culture thereof has an immune enhancing effect by increasing the number of lymph node cells specific for an antigen.

Assignments (5)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 31, 2016
From: UNHWA CORPORATION
To: WELLKEY HOLDINGS LIMITED
Reel/Frame 040174/0316 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 31, 2016
From: JIN, YOUNG WOO
To: WELLKEY HOLDINGS LIMITED
Reel/Frame 040174/0500 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 31, 2016
From: LEE, EUN KYONG
To: WELLKEY HOLDINGS LIMITED
Reel/Frame 040175/0246 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 20, 2013
From: UNHWA CORPORATION
To: UNHWA CORPORATION; JIN, YOUNG WOO; LEE, EUN KYOUNG
Reel/Frame 031641/0278 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 28, 2011
From: LIM, MIN JUNG; JIN, YOUNG WOO; LEE, EUN KYONG
To: UNHWA CORPORATION
Reel/Frame 027137/0337 →
Priority Claims (1)
KR 10-2009-0015040 · Feb 23, 2009 · national
Continuity (1)
Related Publication 20120039918A1 · Feb 16, 2012